Reduced Risk, Upcoming Pipeline Inspire Bull Case For Novartis By: Benzinga via Benzinga July 26, 2017 at 15:52 PM EDT Novartis AG (ADR) (NYSE: NVS) has been all over the news lately as its cancer drug moves closer to FDA approval, and Morgan Stanley ... Read More >> Related Stocks: Novartis Ag ADR